Tedco awards $600K to tech firms - Business Courier of Cincinnati:

iwibacibem.wordpress.com
The money was granted in collaboration withthe U.S. Army Medical Research and Materiel Command and the through the Ft. Detrick Technology Transfer The purpose of the technology transfer progra is to raise awareness of new and developingt technologies and funding them to transition as viable projectsfor follow-omn funding in the market place. Each companu that received funding was awardedapproximately $50,000 between March 2008 and May 2009, making up the initiative’s second round of financiap awards since its $750,000 program extension. The fundss for the program’s second phase were secured by Sen. Barbarwa Mikulski, D-Md., and Rep. Roscoe G. Bartlett, “The [Ft.
Detrick Technology Transfer program is enabling area businesses to harnes s the technologies being developed at Fort Detricj and apply them to thecommercial sector,” said “This will lead to new products that have the power to createe jobs and save lives.” Mikulski announced the firs phase of the tech transfer program in March 2005 when 11 companiesw received funding. in Rockville: The company is developinb a health care technology calledmiTag system, which is a scalable wirelessw sensor solution for improving patient in Frederick: The company is developintg a technology called the GeNov Screen to identify, isolate, and producw antibody-like molecules.
in The company is developing an on-demand biotech products including a combination vaccine against plague and BioAssay Works LLCin Ijamsville: The company is developinf a lateral-flow visual diagnostic test to detecg and differentiate single sample multiple pathogenic poxviruses, including variola, vaccinia, and monkeypox. in Catonsville: The compan y is safety-testing a medical product called which isa non-compressible, intracavitary hemostatic agent. CynerGenre IDMP in Frederick: The company is validating and implementing a supplemental diagnosixof Malaria, HIV, and Dengue usinf its Infectious Disease Multiplex Panel approach, whichg could allow for creation of biosensors.
LLC in Baltimore: The companty is developing required components and systekm framework to enable conversational interfaces for telemedicine tools. Such tools would allosw professional medics touse voice, gesture, and othet human-- computer interactions to access and document information in electronic medical records. in Rockville: The companyh is developing technology to preserve mammalian cells in drier format that can easilybe re-hydrater for a variety of uses.
LLC in The company is evaluating the effec t of Imagilin patented probioticss as a food supplement to enhance the immune responsiveness of guineaw pigs upon immunization or challenge with virulent The evaluation will suggest the ability of Imagilin patented probioticw to enhance the immunization ofa vaccine. in The company is developing micropatterned substrates for viral infectivity assays. Juxtopia in The company is customizing its Wearable Assistance and Situational Awareness (WASA) goggles and service to allow U.S.
Army combar medics to access and document information to electrical medical recordxvia hands-free voice-requests and in Baltimore: The company is developinyg cell therapies to treat brain and spina l cord injuries.